Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A O Naghavi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Brachytherapy|March 27, 2017
American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapyA O Naghavi, D C Fernandez, N Mesko, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 1, 2019
Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapyG Q Yang, R Mhaskar, A Rishi, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 28, 2018
Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancerP S Venkat, R Shridhar, A O Naghavi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 10, 2020
Stereotactic Pelvic Reirradiation for Locoregional Cancer RelapseR Kinj, J Doyen, J M Hannoun-Lévi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 4, 2022
Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancerS Sumodhee, L Guo, L Bouhlel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2016
Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapyK A Ahmed, Y A Abuodeh, M I Echevarria, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Brachytherapy|March 27, 2017
American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapyA O Naghavi, D C Fernandez, N Mesko, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 1, 2019
Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapyG Q Yang, R Mhaskar, A Rishi, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 28, 2018
Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancerP S Venkat, R Shridhar, A O Naghavi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 10, 2020
Stereotactic Pelvic Reirradiation for Locoregional Cancer RelapseR Kinj, J Doyen, J M Hannoun-Lévi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 4, 2022
Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancerS Sumodhee, L Guo, L Bouhlel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2016
Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapyK A Ahmed, Y A Abuodeh, M I Echevarria, et al.
Pageof 1